Cervical cancer (CC) represents the fourth most common malignancy affecting women all
over the world and is the second most common in developing areas. In these areas, the …

Cervical cancer is the most common malignancy amongst females in developing countries,
mainly due to a lack of precursor screening. This absence of screening is the result of …

Cervical cancer remains the most common malignancy amongst females in countries of low
income, mainly due to a lack of screening. Responsible factors are centred around …

Cervical cancer remains the most common cancer among women living in developing
countries, largely because of the failure either to initiate or sustain effective cervical-cancer …

Cervical cancer (CC) is the leading cause of cancer‐related death among women in sub‐
Saharan Africa, primarily because of limited access to effective screening and preventive …

Introduction Cervical cancer is the leading cause of cancer deaths in women in the
developing world. New technologies have been developed to allow for more rapid, cost …

In developing countries, cervical cancer remains a clinical problem of public health
proportions. Eighty percent of the approximately 400,000 new cases of cervical cancer each …

Organised, cytology-based cervical screening has led to a reduction in deaths associated
with cervical cancer. Human papillomavirus (HPV) is necessary for the development of …

Cervical cancer is both preventable and curable, yet it remains one of the leading causes of
mortality in women worldwide. Approximately 88% of cervical cancer cases are diagnosed …

Background: In many low-resource settings, there are barriers to cytologic screening for
cervical cancer. This study evaluates human papillomavirus (HPV) DNA testing as an …